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Edited by Angel NebredaAbstract The c-Jun N-terminal kinase (JNK) signalling path-
way has an established role in cellular stress signalling, cell sur-
vival and tumorigenesis. Here, we demonstrate that inhibition of
JNK signalling results in partial delocalization of the RNA heli-
case DDX21 from the nucleolus to the nucleoplasm, increased
nucleolar mobility of DDX21 and inhibition of rRNA processing.
Furthermore, our results show that JNK signalling regulates
DDX21 phosphorylation and protein expression. In conclusion,
the results presented in this study reveal a previously unidentiﬁed
cellular role for JNK signalling in the regulation of nucleolar
functions. Based on these results, we propose that JNK-mediated
eﬀects on nucleolar homeostasis and rRNA processing should be
considered when interpreting cellular phenotypes observed in
JNK-deﬁcient cell and animal models.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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All organisms need to respond to stress by diﬀerent means in
order to adapt to changes in their environment. Stress stimuli
have been shown to activate the members of the mitogen-acti-
vated protein kinase family (MAPK), including the p38
MAPK, the ERK and the c-Jun protein kinases (JNK). The
JNK pathway is activated upon diﬀerent stress stimuli such
as UV-B radiation, hyperosmotic shock and oxidative damage.
Activated JNK is known to phosphorylate various target pro-
teins such as c-Jun, ATF2 and Elk1 [1]. In addition to its func-
tions in stress regulation, the JNK signalling pathway has an
important role in the positive regulation of cell proliferation
and survival and has therefore been implicated in tumorigene-
sis [2,3].
The nucleolus is a nuclear domain responsible for regulation
of ribosome biogenesis, ribosomal (rRNA) processing, and*Corresponding author. Address: Center for Biotechnology, Univer-
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doi:10.1016/j.febslet.2008.08.004compartmentalization of nuclear proteins [4]. The nucleolus
comprise of a vast number of proteins with various functions
and distinct nucleolar localization [5]. Recently, additional
functions such as regulation of cell cycle, cellular stress re-
sponse signalling and telomerase activity have been attributed
to the nucleolus [4,6]. The nucleolus is known to respond rap-
idly to stress signals, and recent studies have characterized a
plethora of proteins moving rapidly in or out from the nucleo-
lus in response to cellular stress [7]. Furthermore, the rapid
nucleolar translocation of the nucleolar proteins HDM2 and
B23 upon DNA damage has been shown to be essential for a
proper DNA damage response through stabilization of p53
protein levels [8,9].
Several recent studies have suggested a close connection be-
tween JNK signalling and nucleolar functions: stress-activated
JNK inhibits ribosomal RNA (rRNA) synthesis through phos-
phorylation of the transcription factor TIF-IA [6], induces
nucleoplasmic translocation of nucleolar RNA helicase
DDX21 [10], and mediates stress-induced nucleolar shuttling
of the nucleolar proteins B23 and p19Arf [11]. All these results
clearly indicate that stress-induced JNK activation results in
changes in both location and function of several nucleolar pro-
teins.
In this study, we demonstrate that in addition to mediating
cellular stress response, JNK signalling have an important role
in the regulation of nucleolar homeostasis in non-stressed cells.
We show that both genetic and chemical inhibition of JNK sig-
nalling results in partial nucleoplasmic translocation of
DDX21. Our results indicate that the observed nucleolar trans-
location of DDX21 is possibly due to JNK-mediated phos-
phorylation. Moreover, chemical suppression of JNK
signalling inhibits accumulation of the mature 18S and 28S
rRNA subunits. Taken together, results presented here indi-
cate a novel role for JNK signalling in maintaining nucleolar
homeostasis and rRNA processing in non-stressed cells.2. Materials and methods
2.1. Cell culture, cloning
HT1080 cells were obtained from ATCC. The c-Jun, JNK1 / and
JNK2 / knockout mouse embryonal ﬁbroblasts (MEFs) used for
the study have been previously published [12,13]. The JNK null
(JNK1,2 /) MEFs were established by crossing JNK2 / and
JNK1 +/ mice. The embryos were isolated at E9. Heart, liver and
head was removed and used for genotyping. The remaining embryonic
tissue was homogenized with pipetting, plated on a six-well plate andation of European Biochemical Societies.
Table 1
Mutagenesis primers used to produce alanine EGFP-DDX21 mutants
Mutation Sequences
S71A 50-GAAGTTGACATGAATGCTCCTAAATCCAAA-30
S71Arev 50-TTTGGATTTAGGAGCATTCATGTCAACTTC-30
S89A 50-CCATCTCAAAATGACATTGCTCCTAAAACC-30
S89Arev 50-GGTTTTAGGAGCAATGTCATTTTGAGATGG-30
S121A 50-AAATGAGGAGCCTGCTGAGGAAGAAATAGA-30
S121Arev 50-TCTATTTCTTCCTCAGCAGGCTCCTCATTT-30
S171A 50-CTGCCAGTGAAGAAGATAACAGTGAGATAG-3 0
S171Arev 50-CTATCTCACTGTTATCTTCTTCACTGGCAGGGT-30
L264A-L266A 50-CCGTGCCCCTCAGGTAGCGGTTGCTGCACCTACAAGAGAGTTGG-3 0
L264A-L266Arev 50-CCAACTCTCTTGTAGGTGCAGCAACCGCTACCTGAGGGGCACGG-3 0
Nucleotides in bold indicate the point mutations.
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(HyClone) and 10 lg/ml of Gentamycin (GIBCO). After 4 passages
the cells were changed to DMEM (Invitrogen) supplemented with
10% FCS (HyClone), 4 lg/ml of non-essential amino acids, 10 lg/ml
of Gentamycin (GIBCO). All cells were cultured at 37 C in 5% CO2
in Dulbeccos modiﬁed Eagles medium (Invitrogen), supplemented
with 10% heat-inactivated fetal calf serum (FCS; Invitrogen) and pen-
icillin–streptomycin (100 IU/ml and 100 mg/ml, respectively). EGFP-
DDX21 constructs were obtained from EGFP-DDX21 [14] following
the QuikChange II Site-Directed Mutagenesis Kit protocol (Strata-
gene). Mutagenesis primer sequences are listed in Table 1.
The HA-tagged c-Jun constructs, c-Jun WT, c-Jun31–57 and c-JunAla
used in immunoﬂuorescence are described elsewhere [15].
2.2. Immunoﬂuorescence microscopy and photoswitch experiments
Immunostaining of cells grown on coverslips was performed by
simultaneous ﬁxation and permeabilization in 20 mM PIPES, pH
6.8, 4% formaldehyde, 0.2% Triton X-100, 10 mM EGTA, 1 mM
MgCl2, for 10 min at room temperature. Primary antibodies used were
rabbit monoclonal c-Jun (Signal Transduction), mouse monoclonal
HA (Santa Cruz Biotechnology) and human polyclonal DDX21 [16].
Primary antibodies were detected with Cy2- or Cy3-conjugated sec-
ondary antibodies (Jackson Immunoresearch). Wide-ﬁeld ﬂuorescence
microscope images were collected using a Leica DMRE microscope
equipped with a high resolution Hamamatsu Photonics ORCA
C4742-95 CCD camera. Fluorescence intensities were determined
using the Metamorph imaging software (Universal imaging). Relative
nucleoplasm/nucleolus distribution of endogenous DDX21 protein
was quantitated from a representative area of the nucleolus or nucleo-
plasm of 30–50 cells/group.
For FRAP studies cells were transfected with EGFP-DDX21 [14]
and grown on glass plates (MatTek). Size and location of the photo-
bleach or photoswithing area was adjusted with Zeiss LSM 510 version
3.2 software. Fluorescence intensities were measured using photomul-
tiplier tubes connected to the microscope and analyzed using the Zeiss
LSM 510 version 3.2 software, through FITC (Ex. 490BP10 nm, Em.
528BP19 nm). Digital images were superimposed and assembled in
Adobe Photoshop software.
2.3. Quantiﬁcation of protein levels
Samples of subconﬂuent HT1080, MEF wt or JNK1,2 / cells
were processed and analysed by Western blotting using mouse mono-
clonal actin (Santa Cruz Biotechnology), rabbit monoclonal c-Jun
(Signal Transduction), human polyclonal DDX21 [16] and JNK (Sig-
nal Transduction) antibodies. Quantiﬁcations have been done by
MCID imaging analysis software.
2.4. Northern blotting
rRNA processing was studied using rRNA subunit-speciﬁc probes
as described [17]. Shortly the total RNA was isolated using RNeasy
(Qiagen). RNA was separated on a 1% agarose–formaldehyde gel
and blotted on Hybond-N membranes (GE Healthcare). RNA was
separated on a 1% agarose–formaldehyde gel and blotted on Hy-
bond-N membranes. The autoradiogram was exposed and visualized
using a PhosphorImager (Fuji). Quantiﬁcations have been done by
MCID imaging analysis software.2.5. Immunoprecipitation and 32P in vivo labelling
For in vivo labelling experiments cells were preincubated in phos-
phate-free DME (GIBCO BRL) with 1% FCS for 60 min. The medium
was then replaced by phosphate-free DME/10% FBS containing
0.5 mCi/ml 32P-orthophosphate (GE Healthcare). After 3 h, the radio-
active medium was removed and cells were lyzed in lysis buﬀer (1%
Nonindent NP-40, 50 mM Tris, pH 7.4, 0,2 mM EDTA, 0,15 M NaCl,
0.5 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulphonylﬂuoride
(PMSF), 0.5% sodium deoxycholate, 1 mM Na3VO4, 1· complete pro-
tease inhibitor (Roche) for 30 min. The supernatant was incubated
with the human polyclonal DDX21 [16] coupled to protein A Sephar-
ose (Sigma). Immunoprecipitates were then washed three times in lysis
buﬀer followed by addition of Laemmli sample buﬀer. The samples
were resolved on 12.5% SDS–PAGE, and DDX21 phosphorylation
was quantiﬁed using PhosphoImager (Fuji). Quantiﬁcations have been
done by MCID imaging analysis software.3. Results and discussion
3.1. JNK signalling promotes DDX21 nucleolar localization
Although our previous work demonstrated that c-Jun sup-
ports nucleolar localization of DDX21 [17], the role for JNK
in the regulation of DDX21 nucleolar localization has not been
demonstrated. As compared to wild-type mouse ﬁbroblasts,
clearly increased nucleoplasmic staining of DDX21 was ob-
served in immortalized embryonal ﬁbroblasts (MEFs) derived
from JNK1,2 deﬁcient mice (JNK1,2 /) (Fig. 1A). Quanti-
tation of the ratio between nucleoplasmic and nucleolar
DDX21 staining revealed that approximately twice as much
DDX21 was localized to nucleoplasm in JNK1,2 / cells as
compared to wild-type cells (Fig. 1B). This suggests that
JNK activity supports nucleolar localization of DDX21. Inter-
estingly, depletion of JNK1 or JNK2 alone did not produce
any signiﬁcant eﬀects on DDX21 localization, suggesting that
JNK isoforms have redundant functions in regulating DDX21
localization. Nucleoplasmic localization of DDX21 in JNK1,2
/ cells was not due to any clonal eﬀect, as a similar pheno-
type was observed in human HT1080 ﬁbrosarcoma cells trea-
ted with the chemical JNK inhibitor SP600125 (Fig. 1C and
D). No diﬀerence in DDX21 nucleolar localization was ob-
served in HT1080 cells treated with the p38 kinase inhibitor
SB302850 or the MEK1,2 inhibitor PD98059 (Fig. 1C and
D). As no additive eﬀect was observed when the JNK inhibitor
SP600125 was added to the JNK1,2 / cells (Fig. 1E and F),
this indicates that the observed eﬀect of SP600125 on DDX21
nucleolar localization is speciﬁc for JNK signalling. These re-
sults demonstrate that JNK signalling supports DDX21 nucle-
olar localization in non-stressed conditions.
A. Mialon et al. / FEBS Letters 582 (2008) 3145–3151 31473.2. JNK signalling reduces nucleolar shuttling of DDX21
We and others have previously shown that DDX21 shuttles
rapidly between the nucleolus and the nucleoplasm [7,18], and
that c-Jun aﬀects this shuttling [17]. Moreover, we have shown
that nucleoplasmic re-localization of DDX21 correlates with
an increase in its nucleolar mobility and decreased substrate
binding capacity [17]. In order to obtain independent andJN
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Fig. 1. JNK promotes nucleolar localization of DDX21. (A) Localization of
/MEFs as examined by wide-ﬁeld ﬂuorescence microscopy. (B) A graph s
as mean ± S.D. of 50 cells/group. (C) Localization of endogenous DDX21
treatment. (D) A graph showing the ratio of DDX21 staining in nucleoplasm/
endogenous DDX21 in non-treated or SP600125 treated JNK1,2 / ME
showing the ratio of DDX21 staining in nucleoplasm/nucleolus depicted
representing the dominant phenotype observed in the cell population. Eachquantitative evidence for the role of JNK signalling in the reg-
ulation of nucleolar localization of DDX21, we next studied
the nucleolar–nucleoplasmic shuttling of EGFP-DDX21 in
both non-treated and SP600125 treated HT1080 cells. To this
end, selected nucleoli positive for EGFP-DDX21 were photo-
activated and images were obtained at 30 s intervals and the in-
ward nucleolar movement of DDX21 by ﬂuorescence recoveryJNK1 -/- JNK2 -/- JNK1,2 -/-EF wt
p < 0.01
20 μM PD 20 μM SB 20 μM SPControl
p < 0.01
NK1,2 -/- JNK1,2 -/-
+20 μM SP
endogenous DDX21 in wild-type, JNK1 /, JNK2 / and JNK1,2
howing the ratio of DDX21 staining in nucleoplasm/nucleolus depicted
in HT1080 cells 1 h after 20 lM PD98059, SB302850 and SP600125
nucleolus depicted as mean ± S.D. of 50 cells/group. (E) Localization of
Fs as examined by wide-ﬁeld ﬂuorescence microscopy. (F) A graph
as mean ± S.D. of 50 cells/group. (A, C and E) Shown are images
experiment was repeated two to three times with similar results.
WT JNK1,2 -/-
+ +- -SP 20 μM 1h
c-Jun
JNK1
Actin
DDX21
Actin
+-
SP 20 μM 24h
DDX21
DDX21 protein levels1.0 0.8 0.1 0.05
DDX21 protein levels1.0 0.5
Fig. 3. c-Jun and DDX21 levels are reduced in JNK1,2 / cells. (A)
The protein levels of actin, c-Jun, DDX21 and JNK1 in MEF WT and
JNK1,2 / whole cell extract was examined by Western blot analysis
of the respective proteins. Quantiﬁcation of the DDX21 protein
expression levels is also shown. Quantitation has been done by MCID
imaging analysis software and correlated to actin expression from the
same sample. (B) The protein levels of actin, c-Jun, DDX21 and
phospho-c-Jun in untreated and SP600125 treated (20 lM, 24 h)
HT1080 cells whole cell extract was examined by Western blot analysis
of the respective proteins. (A and B) Quantitation of the DDX21
protein expression levels correlated to actin expression from the same
sample.
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sured. Fig. 2 shows a representative time series of photoacti-
vated nucleoli in untreated and SP600125 treated cells
(Fig. 2A). Quantitation of DDX21 half-time (t1/2) for nucleolar
recovery revealed a signiﬁcantly shorter recovery time for
EGFP-DDX21 in SP600125 treated HT1080 cells. The mean
t1/2 recovery time was 30 s in SP600125 cells compared to
150 s in untreated cells (Fig. 2B). These results, obtained by
an independent method to study the eﬀect of JNK signalling
on DDX21 cellular localization, imply that JNK signalling sta-
bilizes DDX21 nucleolar localization. Taken together with the
data shown in Fig. 1, these results demonstrate a novel role for
JNK signalling in regulating nucleolar shuttling of DDX21.
3.3. JNK signalling regulates DDX21 protein expression
As JNK signalling is known to regulate c-Jun protein expres-
sion, we examined the protein levels of c-Jun and DDX21 in
JNK1,2 / cells. As shown in Fig. 3A the protein levels of
c-Jun were decreased in JNK1,2 / cells and surprisingly also
the protein levels of DDX21 (Fig. 3A). A clear decrease in
DDX21 protein levels was also observed in HT1080 cells trea-
ted for 24 h with SP600125 (Fig. 3B). However, treatment with
the JNK inhibitor SP600125 for 1 h did not have a clear eﬀect
on the protein levels of c-Jun, DDX21 and JNK in wild-type
MEFs (Fig. 3A). Therefore, the eﬀects of SP600125 on
DDX21 localization (Fig. 1), shuttling (Fig. 2) and phosphor-
ylation (Fig. 4A) are likely not due to decreased DDX21 pro-
tein levels. These results implicate that JNK signalling not only
promotes nucleolar localization of DDX21 but also supports
DDX21 expression.
3.4. JNK regulates DDX21 phosphorylation
One putative mechanism by which JNK signalling could reg-
ulate DDX21 nucleolar localization is by protein phosphoryla-
tion. To study this possibility, we compared DDX21 32PC
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In addition, DDX21 phosphorylation was compared between
JNK1,2 / and c-Jun / MEFs, both displaying partial
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A. Mialon et al. / FEBS Letters 582 (2008) 3145–3151 3149Fig. 4A, DDX21 phosphorylation was diminished in SP600125
treated (1 h) cells. Moreover, DDX21 phosphorylation was
clearly decreased in JNK1,2 / cells as compared to c-Jun
/ cells (Fig. 4A). These results demonstrate that JNK activ-
ity increases DDX21 phosphorylation and suggests that even
though comparable DDX21 re-localization is seen in both
JNK1,2 / and c-Jun / cells, the mechanism by which
JNK and c-Jun regulate DDX21 localization might be diﬀer-
ent. In order to study more closely how JNK aﬀects DDX21
localization we mutated two leucines to alanine of the potential
JNK-binding site ([1]; LVL; L262A, L264A) on DDX21, and
studied the nucleolar localization of DDX21. Interestingly,
DDX21 harbouring a mutation in the putative JNK binding
site was clearly more localized to the nucleoplasm than thewild-type DDX21 (Fig. 4B). Several reports have indepen-
dently identiﬁed the serines; 71, 89, 121, 171 as phosphorylated
on DDX21 [19,20]. Of these sites serine S171 has a proline in
+1 position, making it a potential phosphorylation site for
JNK [1]. To study if any of the serines are important for
DDX21 nucleolar localization we made serine to alanine point
mutations on these sites and studied the nucleolar localization
of DDX21 (Fig. 4C). As evident from Fig. 4C, a mutation of
serine 171 to alanine (S171A) clearly resulted in a nucleoplas-
mic localization of DDX21, whereas mutation of serines 71
(S71A), 89 (S89A), or 121 (S121A), did not aﬀect DDX21
nucleolar localization. These results together suggest that
JNK signalling regulates DDX21 nucleolar localization
through a phosphorylation-dependent mechanism.
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Fig. 5. Chemical suppression of JNK activity inhibits 28S and 18S
rRNA accumulation. 32S, 28S, 18S and 12S rRNA subunit abundance
was examined by Northern blot analysis in non-treated and SP600125
(20 lM, 24 h) treated HT1080 cells. Fold diﬀerences in rRNA
accumulation are indicated in relation to 32S rRNA.
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through diﬀerent mechanisms
We recently demonstrated that c-Jun depletion results in
similar nucleoplasmic relocalization of DDX21 as is observed
here with JNK inhibition [17]. On the other hand our results
above show diﬀerent levels of DDX21 phosphorylation in c-
Jun or JNK depleted cells (Fig. 4A). We therefore next studied
whether inhibition of JNK regulates DDX21 nucleolar locali-
zation through phosphorylation of c-Jun. To this end, we stud-
ied if a transiently transfected c-Jun WT, JNK-deﬁcient
binding mutant of c-Jun (c-JunD31–57) and a c-Jun mutant
where the known JNK phosphorylation sites on c-Jun, Serine
63 and 73 and Threonine 91 and 93, are mutated to Alanine (c-
JunAla) [15], are able to rescue the nucleoplasmic localization
of DDX21 in c-Jun / cells. As shown in Fig. 4D, c-Jun
WT, c-JunD31–57 and c-JunAla all rescued DDX21 nucleolar
localization in c-Jun / cells indicating that c-Jun-mediated
regulation of DDX21 localization is independent of its JNK-
mediated phosphorylation. These results indicate that JNK-
c-Jun signalling pathway supports DDX21 nucleolar localiza-
tion, but that both JNK and c-Jun exert their eﬀects on
DDX21 at least partly by independent mechanisms.
3.6. JNK signalling reduces rRNA processing
It is well established that rRNA processing occurs in the
nucleolus and that the RNA helicase DDX21 plays a role in
this process [4,5,16]. We recently reported that c-Jun regulates
DDX21s nucleolar localization and rRNA processing [17]. As,
we show in this study that JNK signalling regulates DDX21s
nucleolar localization and protein levels we next wanted to
study whether JNK signalling also aﬀect rRNA processing.
In order to study the eﬀect of JNK signalling on rRNA pro-
cessing the steady state abundance of 32S, 28S, 18S and 12S
rRNA in non-treated and SP600125 treated (24 h) HT1080
cells was quantiﬁed by Northern blot analysis. Fig. 5 clearly
shows that suppression of JNK signalling by SP600125 results
in inhibition of 28S and 18S rRNA accumulation. Therefore,
JNK signalling not only regulates the nucleolar localizationof DDX21 but leads to inhibition of rRNA processing. Taken
together, this work demonstrates that JNK signalling regulates
DDX21 localization, protein levels and rRNA processing in
non-stressed cells. As both stress-elicited JNK activation [10],
and JNK inhibition (Fig. 1) aﬀects nucleolar localization of
DDX21, it indicates that there exists a delicate balance in
the regulation of DDX21 nucleolar localization in both resting
and stressed cells.
In conclusion our results clearly indicate that phenotypes
previously observed in JNK depleted cells [1–3] might not only
be mediated by the already identiﬁed JNK substrates, but
could be at least partly due to nucleolar JNK eﬀects reported
in this study.
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